192 related articles for article (PubMed ID: 29273482)
1. A novel host-protein assay outperforms routine parameters for distinguishing between bacterial and viral lower respiratory tract infections.
Stein M; Lipman-Arens S; Oved K; Cohen A; Bamberger E; Navon R; Boico O; Friedman T; Etshtein L; Paz M; Gottlieb TM; Kriger O; Fonar Y; Pri-Or E; Yacobov R; Dotan Y; Hochberg A; Grupper M; Chistyakov I; Potasman I; Srugo I; Eden E; Klein A
Diagn Microbiol Infect Dis; 2018 Mar; 90(3):206-213. PubMed ID: 29273482
[TBL] [Abstract][Full Text] [Related]
2. A host-protein signature is superior to other biomarkers for differentiating between bacterial and viral disease in patients with respiratory infection and fever without source: a prospective observational study.
Ashkenazi-Hoffnung L; Oved K; Navon R; Friedman T; Boico O; Paz M; Kronenfeld G; Etshtein L; Cohen A; Gottlieb TM; Eden E; Chistyakov I; Srugo I; Klein A; Ashkenazi S; Scheuerman O
Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1361-1371. PubMed ID: 29700762
[TBL] [Abstract][Full Text] [Related]
3. Validation of a Novel Assay to Distinguish Bacterial and Viral Infections.
Srugo I; Klein A; Stein M; Golan-Shany O; Kerem N; Chistyakov I; Genizi J; Glazer O; Yaniv L; German A; Miron D; Shachor-Meyouhas Y; Bamberger E; Oved K; Gottlieb TM; Navon R; Paz M; Etshtein L; Boico O; Kronenfeld G; Eden E; Cohen R; Chappuy H; Angoulvant F; Lacroix L; Gervaix A
Pediatrics; 2017 Oct; 140(4):. PubMed ID: 28904072
[TBL] [Abstract][Full Text] [Related]
4. A host-protein based assay to differentiate between bacterial and viral infections in preschool children (OPPORTUNITY): a double-blind, multicentre, validation study.
van Houten CB; de Groot JAH; Klein A; Srugo I; Chistyakov I; de Waal W; Meijssen CB; Avis W; Wolfs TFW; Shachor-Meyouhas Y; Stein M; Sanders EAM; Bont LJ
Lancet Infect Dis; 2017 Apr; 17(4):431-440. PubMed ID: 28012942
[TBL] [Abstract][Full Text] [Related]
5. Observational multi-centre, prospective study to characterize novel pathogen-and host-related factors in hospitalized patients with lower respiratory tract infections and/or sepsis - the "TAILORED-Treatment" study.
van Houten CB; Oved K; Eden E; Cohen A; Engelhard D; Boers S; Kraaij R; Karlsson R; Fernandez D; Gonzalez E; Li Y; Stubbs A; Moore ERB; Hays JP; Bont LJ
BMC Infect Dis; 2018 Aug; 18(1):377. PubMed ID: 30086729
[TBL] [Abstract][Full Text] [Related]
6. Combined use of biomarkers for distinguishing between bacterial and viral etiologies in pediatric lower respiratory tract infections.
Zhu G; Zhu J; Song L; Cai W; Wang J
Infect Dis (Lond); 2015 May; 47(5):289-93. PubMed ID: 25712729
[TBL] [Abstract][Full Text] [Related]
7. A novel host-proteome signature for distinguishing between acute bacterial and viral infections.
Oved K; Cohen A; Boico O; Navon R; Friedman T; Etshtein L; Kriger O; Bamberger E; Fonar Y; Yacobov R; Wolchinsky R; Denkberg G; Dotan Y; Hochberg A; Reiter Y; Grupper M; Srugo I; Feigin P; Gorfine M; Chistyakov I; Dagan R; Klein A; Potasman I; Eden E
PLoS One; 2015; 10(3):e0120012. PubMed ID: 25785720
[TBL] [Abstract][Full Text] [Related]
8. A prospective, multi-centre US clinical trial to determine accuracy of FebriDx point-of-care testing for acute upper respiratory infections with and without a confirmed fever.
Shapiro NI; Self WH; Rosen J; Sharp SC; Filbin MR; Hou PC; Parekh AD; Kurz MC; Sambursky R
Ann Med; 2018 Aug; 50(5):420-429. PubMed ID: 29775092
[TBL] [Abstract][Full Text] [Related]
9. A host signature based on TRAIL, IP-10, and CRP for reducing antibiotic overuse in children by differentiating bacterial from viral infections: a prospective, multicentre cohort study.
Papan C; Argentiero A; Porwoll M; Hakim U; Farinelli E; Testa I; Pasticci MB; Mezzetti D; Perruccio K; Etshtein L; Mastboim N; Moscoviz E; Ber TI; Cohen A; Simon E; Boico O; Shani L; Gottlieb TM; Navon R; Barash E; Oved K; Eden E; Simon A; Liese JG; Knuf M; Stein M; Yacobov R; Bamberger E; Schneider S; Esposito S; Tenenbaum T
Clin Microbiol Infect; 2022 May; 28(5):723-730. PubMed ID: 34768022
[TBL] [Abstract][Full Text] [Related]
10. Combination of biomarkers for the discrimination between bacterial and viral lower respiratory tract infections.
ten Oever J; Tromp M; Bleeker-Rovers CP; Joosten LA; Netea MG; Pickkers P; van de Veerdonk FL
J Infect; 2012 Dec; 65(6):490-5. PubMed ID: 22898387
[TBL] [Abstract][Full Text] [Related]
11. Host test based on tumor necrosis factor-related apoptosis-inducing ligand, interferon gamma-induced protein-10 and C-reactive protein for differentiating bacterial and viral respiratory tract infections in adults: diagnostic accuracy study.
Halabi S; Shiber S; Paz M; Gottlieb TM; Barash E; Navon R; Ilan-Ber T; Shani L; Petersiel N; Grupper M; Simon E; Kirshner D; Haber D; Stein M; Maor Y; Guetta C; Lishtzinsky Y; Yanai S; Drescher MJ; Oved K; Eden E; Neuberger A; Paul M
Clin Microbiol Infect; 2023 Sep; 29(9):1159-1165. PubMed ID: 37270059
[TBL] [Abstract][Full Text] [Related]
12. Automating a new host-protein assay for differentiating bacterial from viral infection to reduce operator hands-on time.
Shapira M; Boico O; Cohen A; Sagi R; Aharon A; Navon R; Kronenfeld G; Maler K; Pri-Or E; Stein M; Klein A; Eden E; Oved K
Biotechniques; 2018 Aug; 65(2):93-95. PubMed ID: 30091387
[TBL] [Abstract][Full Text] [Related]
13. Identifying patients with bacterial infections using a combination of C-reactive protein, procalcitonin, TRAIL, and IP-10 in the emergency department: a prospective observational cohort study.
van der Does Y; Rood PPM; Ramakers C; Schuit SCE; Patka P; van Gorp ECM; Limper M
Clin Microbiol Infect; 2018 Dec; 24(12):1297-1304. PubMed ID: 30268671
[TBL] [Abstract][Full Text] [Related]
14. Value of serum procalcitonin, neopterin, and C-reactive protein in differentiating bacterial from viral etiologies in patients presenting with lower respiratory tract infections.
Ip M; Rainer TH; Lee N; Chan C; Chau SS; Leung W; Leung MF; Tam TK; Antonio GE; Lui G; Lau TK; Hui DS; Fuchs D; Renneberg R; Chan PK
Diagn Microbiol Infect Dis; 2007 Oct; 59(2):131-6. PubMed ID: 17662560
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein in viral and bacterial respiratory infection in children.
Korppi M; Kröger L
Scand J Infect Dis; 1993; 25(2):207-13. PubMed ID: 8511515
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic utility of CRP to neopterin ratio in patients with acute respiratory tract infections.
Rainer TH; Chan CP; Leung MF; Leung W; Ip M; Lee N; Cautherley GW; Graham CA; Fuchs D; Renneberg R
J Infect; 2009 Feb; 58(2):123-30. PubMed ID: 19073345
[TBL] [Abstract][Full Text] [Related]
17. The course of C-reactive protein response in untreated upper respiratory tract infection.
Melbye H; Hvidsten D; Holm A; Nordbø SA; Brox J
Br J Gen Pract; 2004 Sep; 54(506):653-8. PubMed ID: 15353049
[TBL] [Abstract][Full Text] [Related]
18. A comparison of host response strategies to distinguish bacterial and viral infection.
Ross M; Henao R; Burke TW; Ko ER; McClain MT; Ginsburg GS; Woods CW; Tsalik EL
PLoS One; 2021; 16(12):e0261385. PubMed ID: 34905580
[TBL] [Abstract][Full Text] [Related]
19. A diagnostic rule for the aetiology of lower respiratory tract infections as guidance for antimicrobial treatment.
Graffelman AW; Knuistingh Neven A; le Cessie S; Kroes AC; Springer MP; van den Broek PJ
Br J Gen Pract; 2004 Jan; 54(498):20-4. PubMed ID: 14965402
[TBL] [Abstract][Full Text] [Related]
20. Validation of a host response test to distinguish bacterial and viral respiratory infection.
Lydon EC; Henao R; Burke TW; Aydin M; Nicholson BP; Glickman SW; Fowler VG; Quackenbush EB; Cairns CB; Kingsmore SF; Jaehne AK; Rivers EP; Langley RJ; Petzold E; Ko ER; McClain MT; Ginsburg GS; Woods CW; Tsalik EL
EBioMedicine; 2019 Oct; 48():453-461. PubMed ID: 31631046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
